Search

Your search keyword '"Das, Mayukh"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Das, Mayukh" Remove constraint Author: "Das, Mayukh"
211 results on '"Das, Mayukh"'

Search Results

1. Streetwise Agents: Empowering Offline RL Policies to Outsmart Exogenous Stochastic Disturbances in RTC

2. High-performance p-type field-effect transistors using substitutional doping and thickness control of two-dimensional materials

3. Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors.

4. Publisher Correction: High-performance p-type field-effect transistors using substitutional doping and thickness control of two-dimensional materials

5. Tree DNN: A Deep Container Network

6. Human-guided Collaborative Problem Solving: A Natural Language based Framework

7. AutoCoMet: Smart Neural Architecture Search via Co-Regulated Shaping Reinforcement

8. NL-Augmenter: A Framework for Task-Sensitive Natural Language Augmentation

10. ANNExR: Efficient Anytime Inference in DNNs via Adaptive Intermediate Decision Points

11. Design and Develop Hardware Aware DNN for Faster Inference

12. User Friendly Automatic Construction of Background Knowledge: Mode Construction from ER Diagrams

13. One-Shot Induction of Generalized Logical Concepts via Human Guidance

14. Knowledge-augmented Column Networks: Guiding Deep Learning with Advice

15. Human-Guided Learning of Column Networks: Augmenting Deep Learning with Advice

16. Preference-Guided Planning: An Active Elicitation Approach

20. A design strategy for high-performance p-type two-dimensional field effect transistors

21. COIN: Chance-Constrained Imitation Learning for Uncertainty-aware Adaptive Resource Oversubscription Policy

22. Risk-aware Adaptive Virtual CPU Oversubscription in Microsoft Cloud via Prototypical Human-in-the-loop Imitation Learning

25. Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

27. Supplementary Data from First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

28. Data from First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

29. A Design Strategy for High-performance p-type Two-dimensional Field Effect Transistors

30. Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors

31. Supplementary Table from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

32. Data from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

33. Supplementary Figure from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

35. Automated Spot Counting in Microbiology

38. Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

41. Abstract CT126: A phase 2 trial of first-line AZD0171 + durvalumab and chemotherapy (CT) in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and CD8+ T cell infiltration

44. Phenotype-Based Threat Assessment

45. Phytohormone Priming of Tomato Plants Evoke Differential Behavior in Rhizoctonia solani During Infection, With Salicylate Priming Imparting Greater Tolerance Than Jasmonate

46. Anticipated pharmacological role of Aviptadil on COVID-19

49. Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study

50. First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

Catalog

Books, media, physical & digital resources